108
Participants
Start Date
March 16, 2021
Primary Completion Date
January 16, 2024
Study Completion Date
January 16, 2024
ChAdOx1-HPV
Trial vaccine
MVA-HPV
Trial vaccine
Placebo
Saline placebo vaccine
Erasme Hospital, Brussels
UZ Brussel, Brussels
UZA, Antwerp
UZ Leuven, Leuven
UZ Gent, Ghent
East-Tallinn Central Hospital, Tallinn
North Estonia Medical Centre Foundation Surgery Clinic, Tallinn
Tartu University Hospital Womens Clinic, Tartu
Parnu Hospital Womens and Childrens Clinic, Pärnu
Aberdeen Royal Infirmary, Aberdeen
University Hospital Bristol NHS Trust, Bristol
Liverpool Women's NHS Foundation Trust, Liverpool
Royal Victoria Infirmary, Newcastle upon Tyne
Nottingham University Hospital NHS Trust, Nottingham
The University of Oxford, Nuffield Department of Women's & Reproductive Health, Oxford
Royal Preston Hospital, Preston
Lead Sponsor
Barinthus Biotherapeutics
INDUSTRY